TABLE 2.
Rate of histologic recurrence (%)
Group 1 (GN: no steroids) |
Group 3 (GN: steroids) |
||||||||
---|---|---|---|---|---|---|---|---|---|
N | 1 yr | 5 yr | 7 yr | n | 1 yr | 5 yr | 7 yr | P | |
Focal segmental GN | 61 | 17 | 28.8 | 28.8 | 49 | 6.4 | 9.2 | 12.3 | 0.02 |
Membranous nephropathy | 12 | 8 | 31 | 31 | 12 | 0 | 0 | 10a | 0.04 |
Membranoproliferativea | 18 | 5.5 | 11.2 | 31 | 31 | 6.7 | 11 | 16 | 0.5 |
IgA nephropathy | 65 | 1.6 | 8.8 | 22 | 66 | 1.6 | 3.3 | 5.2 | 0.02 |
Chronic GN | 27 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | |
SLE | 15 | 0 | 0 | 0 | 22 | 0 | 0 | 0 | |
Rapidly progressive GN | 8 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | |
Anti-GBM | 3 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | |
Henoch-Schonlein purpura | 4 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | |
Wegener’s granulomatosis | 2 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | |
Overall recurrence rate (%) | 6.7 | 13.7 | 19.2 | 2.4 | 3.8 | 5.3 | <0.0001 |
All MPGN types.
GN, glomerulonephritis; SLE, systemic lupus erythematosus; GBM, glomerular basement membrane.